YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Economic Value of Pharmaceutical Care for the Elderly Patients in Community Pharmacies

노인환자에게 제공하는 개국약국 약료서비스의 경제적 가치

  • Published : 2007.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study was to evaluate economic impact of a comprehensive pharmaceutical care intervention provided by community pharmacists on drug-related morbidity and mortality in the elderly population, in a societal perspective. Clinical outcomes of pharmaceutical care included compliance increase, inappropriate medication discontinuation, and subsequent drug-related morbidity and mortality reduction. Economic outcomes included cost savings from direct medical costs reduction such as medication and healthcare resource utilization. Input costs for pharmaceutical care included pharmacist time and computerized prescription review supporting program costs. Model parameters of outcomes were derived from published literatures, and costs were from literatures and health insurance statistical data in Korea. Annual costs and benefits were estimated in the year 2005. Current usual care and standardized pharmaceutical care required 0.3 and 2.0 hours per year respectively, for elderly outpatient using average 4.4 prescription drugs per visit and average annual frequency of 17.8 pharmacy visits. Comprehensive pharmaceutical care provided to overall elderly outpatients at community pharmacies would have cost of \74,994 mil. and benefit of \357,002 mil. per year. Benefit:cost ratio was 4.8:1 and net benefit was \282,008 mil/year. It was corresponded to net benefit of \73,816/year for individual elderly patient. In addition, pharmaceutical care was estimated to reduce 1,531 drug-related deaths/year. Conclusively this study, a first attempt in Korea to evaluate an economic value of pharmaceutical care at community pharmacies, proved that it was a cost-effective intervention having significant economic benefit.

Keywords

References

  1. Winterstein, A. G., Sauer, B. C, Hepler, C. D. and Poole, C. : Preventable drug-related hospital admission. Ann. Pharmacother. 36, 1238 (2002)
  2. Lazarou, J., Pomeranz, B. H. and Corey, P. N. : Incidence of adverse drug reactions in hospitalized patients: a meta-analyis of prospective studies. JAMA 279, 1200 (1998)
  3. Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K. and Breckenridge, A. M. : Adverse drug reaction as cause of admission to hospital: prospective analysis of 18820 patient. BMJ 329, 15 (2004) https://doi.org/10.1136/bmj.329.7456.15
  4. Howard, R. L., Avery, A. J., Howard, P. D. and Patridge, M. : Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual. Saf. Health Care 12, 280 (2003) https://doi.org/10.1136/qhc.12.4.280
  5. Beijer, H. J. and de Blaey, C. J. : Hospitalizations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm. World. Sci. 24(2), 46 (2002)
  6. Johnson, J. A. and Bootman, J. L.: Drug-related morbidity and mortality: A cost-of-illness model. Arch. Intern. Med. 155, 1949 (1995)
  7. Ernst, F. R. and Grizzle, A. J. : Drug-related morbidity and mortality: a cost-of-illness model. J. Am. Pharm. Assoc. 41, 192 (2001)
  8. 강이경 : 건강보험자료를 이용한 의원의 노인 처방경향 및 적절성 평가. 숙명여대 임상약학대학원 학위논문 (2006)
  9. 오정미 : 한국 노인환자의 약물사용 현황 분석 및 적절성 연구. 식품의약품안전청 (2004)
  10. 김진현, 김정회 : 중복처방 의약품의 실태조사. 건강보험심사평가원 (2005)
  11. 김복련, 송경화, 안효자, 정지영, 신재신 : 노인의 약물사용 실태 조사 - 부산시 무료 앙로원을 대상으로. 노인간호학회지 3(2), 208 (2001)
  12. American Society of Hospital Pharmacists. ASHP Statement on Principles for Including Medications and Pharmaceutical Care in Health Care Systems. Am. J. Hosp. Pharm. 50, 756 (1993)
  13. 김진현 등 : 약국의 경영수지분석 및 적정 조제수가의 체계화에 관한 연구 보고서. 인제대학교 보건과학연구소 (2002. 8)
  14. 현효숙, 허란희, 정희정, 최귀숙, 조혜경 : 의약분업 후 약사의 병원 원외 처방전 검토 업무사례 분석 . 병원약사회지 20(1), 1 (2003)
  15. 이상은 : 고령환자에서 약물평가 및 약사개업의 효과. 서울대학교대학원 학위논문 (2006)
  16. 황보영, 오정미 : 신기능을 고려한 H2-receptor antagonist의 용량.용법 및 투여경로의 적절성 및 약사자문의 수용성. 한국의료QA학회지 9(2), 230 (2002)
  17. 권계숙 : 당뇨병이 동반된 고지혈증 환자를 대상으로 한 약사에 의한 lipid management service의 효과. 숙명여자대학교 임상약 학대학원 학위논문 (2002)
  18. 문양임, 오정미 : 혈액투석환자에서 삶의질에 미치는 요인 평가. 병원약사회지 19(3), 269 (2002)
  19. 김귀숙 : 환자측면, 병원약사측면, 병원경영측면에서 본 소아 TPN의 유용성 평가. 병원약사회지 18(4), 453 (2004)
  20. 신문희, 오정미, 정경주, 최승기, 신현택 : 입원한 환자에 대한 약사의 복약지도 서비스 평가. 한국임상약학회지 12(2), 76 (2002)
  21. 배성미, 안혜림, 홍경자, 나현오, 조혜경 : 반코마이신의 임상약동학 모니터링 서비스에 대한 임상적 및 경제적 손익의 평가. 한국임상약학회지 11(1), 1 (2001)
  22. 한은아, 양봉민, 이의경 : 테오필린에 대한 의약물동력학 자문서비스의 비용-편익 분석. 한국의료QA학회지 7(2), 168 (2000)
  23. Schumock, G. T., Meek, P. D., Ploetz, P A. and Vermeulen, L. C. : Economic evaluation of clinical pharmacy services-1988-1995. The publications committee of the american college of clinical pharmacy. Pharmacotherapy 16(6), 1188 (1996)
  24. Schumock, G. T., Butler, M. G., Meek, P. D., Vermeulen, L. C., Arondekar, B. V. and Bauman, J. L. : 2002 Task Force on Economic Evaluation of Clinical Pharmacy Services of the American College of Clinical Pharmacy. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 23(1), 113 (2003) https://doi.org/10.1592/phco.23.1.113.31910
  25. Schappert, S. M. and Burt, C. W. : Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Vital Health Stat. 13(159), 1 (2006)
  26. Hing, E., Cherry, D. K. and Woodwell, D. A. : National ambulatory medical care survey: 2004 summary. Adv. Data 374, 1 (2006 Jun 23)
  27. Faulkner, M. A., Wadibia, E. C, Lucas, B. D. and Hilleman, D. E. : Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy 20(4), 410 (2000)
  28. Ali, E, Laurin, M. Y., Lariviere, C., Tremblay, D. and Cloutier, D. : The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can. J. Clin. Pharmacol. 10(3), 101 (2003)
  29. Rehring, T. F., Stolcpart, R. S., Sandhoff, B. G., Merenich, J. A. and Hollis, H. W. Jr. : Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease. J. Vasc. Surg. 43(6), 1205 (2006) https://doi.org/10.1016/j.jvs.2006.02.019
  30. Hanlon, J. T., Weinberger, M., Samsa, G. P., et al. : A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am. J. Med. 100(4), 428 (1996)
  31. Sookaneknun, P., Richards, R. M., Sanguansermsri, J. and Teerasut, C. L Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann. Pharmacother. 38(12), 2023 (2004) https://doi.org/10.1345/aph.1D605
  32. Phillips, S. L. and Carr-Lopez, S. M. : Impact of a pharmacist on medication discontinuation in a hospital-based geriatric clinic. Am. J. Hosp. Pharm. 47(5), 1075 (1990)
  33. Laucka, P. V. and Hoffman, N. B. : Decreasing medication use in a nursing-home patient-care unit. Am. J. Hosp. Pharm. 49(1), 96 (1992)
  34. Borgsdorf, L. R., Miano, J. S. and Knapp, K. K. : Pharmacist-managed medication review in a managed care system. Am. J. Hosp. Pharm. 51(6), 772 (1994)
  35. Yuan, Y., Hay, J. W. and McCombs, J. S.: Effects of ambulatory-care pharmacist consultation on mortality and hospitalization. Am. J. Manag. Care. 9(1), 45 (2003)
  36. Royal, S., Smeaton, L., Avery, A. J., Hurwitz, B. and Sheikh, A.: Interventions in primary care to reduce medication related adverse events and hospital admission: systematic review and meta-analysis. Qual. Saf. Health. Care 15, 23 (2006) https://doi.org/10.1136/qshc.2004.012153
  37. Cherry, D. K. and Woodwell, D. A. : National ambulatory medical care survey: 2000 summary. Adv. Data 328, 1 (2002 Jun 5)
  38. Briggs, A. and Sculpher, M. : An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 13(4), 397 (1998 Apr)
  39. 건강보험심사평가원. 건강보험통계지표 (2005)
  40. 통계청. 고령자통계 (2005)
  41. 건강보험심사평가원. 정보공개 요청 자료 (2006. 12)
  42. 황인경, 이해종, 최승미 : 2005년도 약국의 적정수가 환산지수 산정 및 합리적 상대가치 개발 연구. 대한약사회 (2004. 12)
  43. Christensen, D. B., Neil, N., Fassett, W. E., Smith, D. H., Holmes, G. and Stergachis, A.: Frequency and characteristics of cognitive services provided in response to a financial incentive. J. Am. Pharm. Assoc. 40, 609 (2000)
  44. Harris, C. M. : The scale of repeat prescribing. Br. J. Gen. Pract. 46, 549 (1996)
  45. Chen, Y. F., Dewey, M. E. and Avery, A. J. : Self-reported medication use for older people in England and Wales. J. Clin. Pharm. Ther. 26(2), 129 (2001)
  46. Stewart, R. B. and Cooper, J. W. : Polypharmacy in the aged. Practical solutions. Drugs Aging 4(6), 449 (1994)
  47. Klarin, I., Wimo, A. and Fastbom, J. : The association of impropriate drug use with hospitalisation and mortality a population-based study of the very old. Drugs Aging 22(1), 69 (2005) https://doi.org/10.2165/00002512-200522010-00005